Epigallocatechin gallate enhances sympathetic heart rate variability and decreases blood pressure in obese subjects: a randomized control trial - Wilasrusmee, Kittikorn Tommy; Sitticharoon, Chantacha; Keadkraichaiwat, Issarawan; Maikaew, Pailin; Pongwattanapakin, Kitchaya; Chatree, Saimai; Sririwichitchai, Rungnapa; Churintaraphan, Malika (Scientific reports, 2024)
Keywords: 631/443; 631/443/319; 631/443/592; 692/163; Adult; Autonomic nervous system; Blindness; Blood pressure; Blood Pressure - drug effects; Catechin - administration & dosage; Catechin - analogs & derivatives; Catechin - pharmacology; Cholesterol; Dietary restrictions; Double-Blind Method; EGCG; Epigallocatechin gallate; Female; Heart rate; Heart Rate - drug effects; High density lipoprotein; Hormones; HRV; Humanities and Social Sciences; Humans; Insulin; Insulin resistance; Leptin; Male; Metabolic; Middle Aged; multidisciplinary; Obesity; Obesity - drug therapy; Obesity - physiopathology; Science; Science (multidisciplinary); Sympathetic Nervous System - drug effects; Obesity; Metabolic; Hormones; HRV; MAP; EGCG